HealthNotableSingle-source
4.9
Patent Expiries Accelerate Brazilian Biopharmaceutical Production for Cancer
Valor Econômico·BR·2 days ago
A 14-year-old Italian boy with osteosarcoma died in December 2022 after his parents opted for an unproven treatment instead of conventional care at the Istituto Ortopedico Rizzoli. The case highlights risks of alternative therapies and potential legal implications for the parents. Details on the specific therapy and legal proceedings remain unclear.
Locations